Vitamin C Forms Compared: Ascorbic Acid, Buffered, Ester-C, Liposomal
Vitamin C Forms Compared: Ascorbic Acid, Buffered, Ester-C, Liposomal
Walk down any supplement aisle and you will find at least four kinds of vitamin C, each promising to work better than the rest.
Ascorbic acid, buffered mineral ascorbates, Ester-C and liposomal formulations all deliver the same molecule. What differs is acidity, tolerability, and how much reaches your bloodstream at higher doses.
That difference is smaller than most marketing suggests. At intakes of 30–180mg a day, your body absorbs 70–90% of plain ascorbic acid. Above 1g, absorption drops to 50% or less. Here is what the evidence shows for each form, including who paid for it.
Key Takeaways
- Form matters far more at high doses than low ones. Plain ascorbic acid is absorbed at 70–90% at intakes of 30–180mg/day, so at everyday amounts there is little room for any alternative form to improve on.
- A 2025 scoping review of 10 trials found liposomal vitamin C produced 1.3–7.2 times higher AUC than non-liposomal forms, though no trial measured how much of that extra was retained rather than excreted.
- The largest review favouring Ester-C covered 13 randomised trials and was funded by Nestlé Health Science, the parent company of the business that owns the Ester-C brand.
- Buffered forms trade acidity for a mineral load: sodium ascorbate supplies 111mg of sodium per 1,000mg, which is worth knowing if you are watching your intake.
- Commercial vitamin C is manufactured from D-glucose, and the starch that glucose comes from is predominantly corn — the one axis most comparisons leave out entirely.
Table of Contents
- Why the Dose Matters More Than the Form
- Ascorbic Acid: The Benchmark Everything Else Is Measured Against
- Buffered Vitamin C: Trading Acidity for Mineral Load
- Ester-C: The Best-Evidenced Alternative, and Who Funded the Evidence
- Liposomal Vitamin C: Strongest Absorption Data, Youngest Evidence Base
- The Column Most Comparisons Leave Out: What Your Vitamin C Is Made From
- Liposomal and Corn-Free: Where Bio Absorb Nutraceuticals Fits
- Frequently Asked Questions
- Conclusion
- Research References
1. Why the Dose Matters More Than the Form
Before comparing forms, it helps to know when the comparison matters at all. Vitamin C is absorbed through a saturable transporter in the small intestine. At low concentrations that transporter does most of the work. At high concentrations it is overwhelmed, and the rest of the dose passes through by simple diffusion or not at all.
The numbers are well established. The Institute of Medicine's reference intake report puts absorption at 70–90% for usual intakes of 30–180mg per day, falling to around 50% or less at single doses above 1g. The landmark 1996 depletion-repletion study that set the modern RDA found bioavailability close to complete at 200mg and roughly 46% at a single 1,250mg dose. That study followed only seven volunteers, so treat the precise figures as a guide rather than a rule.
This is the single most useful fact in the whole comparison. If you take 200mg a day, plain ascorbic acid already delivers most of what your body can hold, and no alternative form has much room to improve on it. If you take 1,000mg or more, roughly half the dose is going to waste, and that is where formulation starts to earn its keep. The mechanics are covered in more depth in our guide to why most of your vitamin C dose is wasted.
2. Ascorbic Acid: The Benchmark Everything Else Is Measured Against
Ascorbic acid is the reference form. It is what most research uses, what most supplements contain, and what every other form is compared against. The NIH Office of Dietary Supplements notes that its bioavailability is equivalent to the ascorbic acid occurring naturally in foods such as orange juice and broccoli.
One myth worth clearing up: natural and synthetic ascorbic acid are chemically identical, and the Linus Pauling Institute reports no known differences in biological activity or bioavailability between them. Paying more for "food-sourced" vitamin C buys you the accompanying plant compounds, not better vitamin C.
Its main drawback is in the name. Ascorbic acid is acidic, and at higher doses some people get diarrhoea, nausea or abdominal cramps. The NIH attributes this to the osmotic effect of the unabsorbed portion moving through the intestine — which is why the problem grows as the dose climbs past the point of efficient absorption. The tolerable upper intake level for adults is 2,000mg per day.
It is also, by a wide margin, the cheapest option. For someone taking a moderate daily dose with no digestive complaints, that combination of low cost and equivalent absorption is difficult to argue with.
3. Buffered Vitamin C: Trading Acidity for Mineral Load
Buffered vitamin C means ascorbic acid bound to a mineral, which raises its pH and makes it gentler on the stomach. Sodium ascorbate and calcium ascorbate are the two you will see most often.
The trade-off is that you swallow the mineral along with the vitamin. According to the Linus Pauling Institute, 1,000mg of sodium ascorbate supplies 111mg of sodium and 889mg of ascorbic acid, while 1,000mg of calcium ascorbate supplies 90–110mg of calcium and 890–910mg of ascorbic acid. At one gram a day that mineral load is modest. At three or four grams it becomes worth counting, particularly for readers managing sodium intake or already taking a calcium supplement.
What buffered forms do not appear to offer is better absorption. The evidence points to comparable bioavailability across mineral ascorbates and plain ascorbic acid, with the difference showing up in comfort rather than blood levels. That is a real benefit if acidity is your limiting factor — it just is not an absorption story.
- Sodium ascorbate: 111mg sodium per 1,000mg — check this against your daily sodium target
- Calcium ascorbate: 90–110mg calcium per 1,000mg — counts toward your calcium intake
- Absorption: comparable to plain ascorbic acid, not superior
- Best suited to: people who get heartburn or stomach upset from ascorbic acid
4. Ester-C: The Best-Evidenced Alternative, and Who Funded the Evidence
Ester-C is a trademarked formulation, not a generic form. It is mainly calcium ascorbate combined with small amounts of vitamin C metabolites, including dehydroascorbic acid, calcium threonate and trace xylonate and lyxonate. The claim is that these metabolites help vitamin C move into and stay inside immune cells.
It has more clinical evidence behind it than any other alternative form. A 2025 systematic review in Nutrients examined 13 randomised trials, seven of them on Ester-C, and rated 10 of the 13 (77%) at low risk of bias. It found significantly better gastrointestinal tolerability: in a trial of 50 adults sensitive to acidic foods, tolerability was rated "very good" by 72% of participants on Ester-C compared with 54% on ascorbic acid. The same review reports an earlier four-way crossover trial in which leukocyte vitamin C was 1.3 to 1.7 times higher at 24 hours with the metabolite formulation than with ascorbic acid alone, with no matching difference in plasma levels.
Two things temper that. First, the dose pattern repeats: the review's largest included trial, in 93 participants, found no significant plasma or leukocyte difference between Ester-C and ascorbic acid at 250mg, with differences appearing only at 500mg. And an independent 1994 study of nine people found no difference at all in absorption or urinary excretion. The Linus Pauling Institute also notes that the manufacturer's own bioavailability study has not been published in a peer-reviewed journal.
Second, and worth stating plainly: that 2025 review discloses that it was funded by Nestlé Health Science, the parent company of the business that owns the Ester-C brand. One author is disclosed as a former member of the Nature's Bounty Co. Scientific Advisory Council. This does not make the findings wrong, and the methodology was sound. It does mean the strongest evidence for Ester-C was paid for by the people selling it, which is context you deserve before you compare it with anything else.
5. Liposomal Vitamin C: Strongest Absorption Data, Youngest Evidence Base
Liposomal formulations wrap ascorbic acid inside phospholipid spheres, similar in composition to cell membranes. The intent is to protect the vitamin through the stomach and partly bypass the saturable transporters that limit standard absorption at higher doses.
The absorption data is the strongest of any alternative form. An independent 2025 scoping review screened 321 studies and included 10. Nine of the ten showed higher bioavailability for liposomal versus non-liposomal vitamin C, with Cmax values 1.2–5.4 times higher and AUC values 1.3–7.2 times higher. That is a wide range, and the review is explicit about why: the trials used very different formulations, doses from 0.15g to 10g, and sampling windows from 4 to 24 hours. One of the better-controlled trials — a double-blind, placebo-controlled crossover in 27 adults at 500mg, rated at low risk of bias in the Nutrients review — found plasma Cmax 27% higher and 24-hour plasma AUC 21% higher than standard ascorbic acid, with smaller gains in leukocytes.
The limitations are real and worth holding onto. No trial in that review measured how much of the extra absorbed vitamin C was eliminated, so it is unclear whether liposomal delivery means more retained or simply more excreted later. No study measured retention in tissues at all. And because liposome size and composition vary so much between manufacturers, results from one product do not automatically transfer to another. The 2025 systematic review described liposomal research as still at an early stage.
The Linus Pauling Institute takes a firmer line, stating that no form of vitamin C has a proven benefit over plain ascorbic acid and that little peer-reviewed literature supports manufacturers' bioavailability claims. That position is a fair reading of the plasma evidence at ordinary doses. Where the picture has shifted since is in AUC and leukocyte measurements at higher doses. Better absorption is well supported; whether it produces better health outcomes in someone whose vitamin C levels are already adequate has not been demonstrated. Liposomal products also cost considerably more than plain ascorbic acid, because encapsulation requires extra ingredients and specialised processing. We go deeper into that comparison in liposomal vitamin C versus regular vitamin C.
6. The Column Most Comparisons Leave Out: What Your Vitamin C Is Made From
Every comparison you will read weighs absorption, acidity and cost. Very few mention where the ascorbic acid came from, and for a meaningful number of people that is the axis that decides the purchase.
Commercial vitamin C is manufactured, not extracted from fruit. Both the classic Reichstein process and the modern two-step fermentation route start from D-glucose obtained by hydrolysing starch, and a 2024 review of the industry's processes and markets identifies that starch as mainly corn starch. Corn dominates largely because it is the cheapest feedstock available, at roughly USD 146 per tonne against 232 for wheat and 261 for molasses. The glucose is converted to sorbitol, then sorbose, then the precursor that becomes ascorbic acid.
Here is why it cuts across the whole comparison: buffered forms and Ester-C are ascorbate salts, and liposomal products encapsulate ascorbic acid. All of them are built on the same starting material. Choosing a different form does not change the source. If you react to corn, or avoid it for other reasons, the form question is secondary to why the source of ascorbic acid matters, and most brands do not disclose it. Verified corn-free vitamin C is uncommon enough that it is worth checking the label before you weigh anything else. If you are working through a purchase decision, our guide on how to choose a liposomal vitamin C supplement walks through the rest of the checks.
7. Liposomal and Corn-Free: Where Bio Absorb Nutraceuticals Fits
Bio Absorb Nutraceuticals makes Liposomal Vitamin C Liquid 1000mg (Corn-Free) and Liposomal Vitamin C Capsules 1000mg (Corn-Free). Both use phospholipid encapsulation, and both are verified corn-free — which, as section 6 explains, is a separate question from which form you choose and one most brands leave unanswered.
The two formats share a formulation and an allergen profile. Both are non-GMO, gluten-free, nut-free, dairy-free and vegan, made in a GMP-certified Canadian facility, non-irradiated, and third-party tested every batch. The liquid mixes with water or juice and has a natural orange flavour, which suits flexible dosing. The capsules need no refrigeration, travel well and have no taste, which suits consistency and convenience. There is no absorption argument between them — it is a practical choice about how you prefer to take it.
Both are covered by a 100% money-back guarantee, and empty bottles do not need to be returned. For current pricing and serving details, see the product pages linked above rather than relying on figures quoted elsewhere, which can go out of date.
Frequently Asked Questions
Is buffered vitamin C better than ascorbic acid?
Better tolerated, not better absorbed. Buffered forms are less acidic, and a trial in acid-sensitive adults found tolerability rated "very good" by 72% on a buffered metabolite formulation against 54% on ascorbic acid. If digestive discomfort is what limits your dose, that is a meaningful advantage. If it is not, you are paying more for a benefit you do not need.
Does Ester-C actually work better, or is that marketing?
Some of both. Ester-C has the largest evidence base of any alternative form, and its tolerability advantage is well supported. But the largest review supporting it was funded by the brand owner's parent company, an independent 1994 study found no absorption difference, and a 93-person trial found no difference at 250mg. The claims are strongest at higher doses and weakest at everyday ones.
Is liposomal vitamin C worth the extra cost?
It depends almost entirely on your dose. At 200mg a day, plain ascorbic acid is already absorbed at 70–90% and there is little headroom. At 1,000mg or more, where standard absorption falls below 50%, the 1.3–7.2 times higher AUC seen in liposomal trials becomes more relevant. Bear in mind that no trial has yet shown that better absorption translates into better health outcomes in people who are already replete.
Does the form change how much I should take?
Not the upper limit. The tolerable upper intake level of 2,000mg per day for adults applies to vitamin C itself, whatever form it arrives in. What form can change is how comfortably you reach a given dose, and how much of it you absorb. Our guide to liposomal vitamin C covers the dose-response picture in more detail.
Are natural and synthetic vitamin C different?
Chemically, no. The Linus Pauling Institute reports no known difference in biological activity or bioavailability between natural and synthetic L-ascorbic acid. Products described as food-sourced may bring along other plant compounds, but the vitamin C itself is the same molecule.
Who should be careful with higher doses of any form?
High intakes can raise urinary oxalate, which matters if you have kidney disease or a history of kidney stones. Vitamin C also increases non-heme iron absorption, which is a concern in haemochromatosis and other iron-overload conditions. Harvard's Nutrition Source flags both groups specifically. If either applies to you, or you take regular medication, discuss your dose with your doctor before increasing it.
Conclusion
The honest summary is that form matters much less than the supplement industry suggests, and it matters mainly at higher doses. Below roughly 200mg a day, where absorption already runs at 70–90%, plain ascorbic acid does the job at the lowest price. Above that, buffered forms buy comfort and liposomal delivery buys absorption, each with evidence that is real but narrower than the marketing implies.
The one axis that applies at every dose is what your vitamin C is made from. If corn is a concern for you, that question outranks the rest — and you can compare Bio Absorb Nutraceuticals' verified corn-free liquid and capsule formats on the product pages above.
Research References
- Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences USA, Vol. 93, No. 8 (1996), pp. 3704–3709. Depletion-repletion study in seven volunteers establishing that bioavailability approaches complete at 200mg and falls to roughly 46% at a single 1,250mg dose.
- Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137 (2025), article e70067. Screened 321 studies and reviewed 10, nine showing higher bioavailability for liposomal vitamin C with Cmax 1.2–5.4 times and AUC 1.3–7.2 times higher, while noting that no trial assessed ascorbate elimination.
- Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults. Nutrients, Vol. 17, No. 2 (2025), article 279. Reviewed 13 randomised trials of alternative vitamin C forms, 10 of them (77%) at low risk of bias, finding better gastrointestinal tolerability for calcium ascorbate with metabolites; funded by Nestlé Health Science.
- Comparison of the absorption and excretion of three commercially available sources of vitamin C. Journal of the American Dietetic Association, Vol. 94, No. 7 (1994), pp. 779–781. Found no difference between Ester-C and ordinary ascorbic acid tablets in absorption or urinary excretion in nine participants.
- Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations. Advances in Therapy, Vol. 25 (2008), pp. 995–1009. Four-way crossover trial reporting leukocyte vitamin C 1.3 to 1.7 times higher at 24 hours with calcium ascorbate plus metabolites than with ascorbic acid alone.
- Comparative effectiveness of ascorbic acid vs. calcium ascorbate ingestion on pharmacokinetic profiles and immune biomarkers in healthy adults: A preliminary study. Nutrients, Vol. 16 (2024), article 3358. Trial in 93 participants finding no plasma or leukocyte difference at 250mg, with differences emerging at 500mg.
- Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. European Journal of Nutrition, Vol. 63 (2024), pp. 3037–3046. Crossover trial in 27 adults at 500mg reporting plasma Cmax 27% higher and 24-hour plasma AUC 21% higher than standard ascorbic acid.
- Safety and tolerance of Ester-C compared with regular ascorbic acid. Advances in Therapy, Vol. 23 (2006), pp. 171–178. Trial in 50 adults sensitive to acidic foods; source of the 72% versus 54% "very good" tolerability comparison.
- Process design and economic studies of two-step fermentation for production of ascorbic acid. SN Applied Sciences (now Discover Applied Sciences), Vol. 2 (2020). Documents ascorbic acid production from D-glucose derived from starch and the relative feedstock costs of corn, wheat and molasses.
- A comprehensive review and recent advances of vitamin C: Overview, functions, sources, applications, market survey and processes. Chemical Engineering Research and Design, Vol. 206 (2024), pp. 108–129. Industry-wide review identifying D-glucose from starch, predominantly corn starch, as the feedstock for commercial vitamin C production.
- Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Institute of Medicine, National Academies Press (2000). Source for the 70–90% absorption range at intakes of 30–180mg/day, the fall to 50% or less above 1g, and the 2,000mg/day upper intake level.
- Vitamin C — Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements (accessed September 2026). Reference for supplemental forms, equivalence of supplemental and dietary ascorbic acid, and the gastrointestinal effects of high doses.
- Vitamin C: Supplemental Forms and Vitamin C. Linus Pauling Institute Micronutrient Information Center, Oregon State University (accessed September 2026). Source for mineral ascorbate composition, the equivalence of natural and synthetic ascorbic acid, and the Institute's position on alternative forms.
- Vitamin C. Harvard T.H. Chan School of Public Health, The Nutrition Source (accessed September 2026). Reference for the tolerable upper intake level and cautions for kidney disease, kidney stone history and haemochromatosis.
About the Author
David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.
Important Disclaimers
Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.
FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.